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Innate and adaptive immune 
dysregulation in critically ill ICU 
patients
Niharika Arora Duggal1, Catherine Snelson2, Ulfath Shaheen1, Victoria Pearce1 & 
Janet M. Lord1,2,3
This study aimed to evaluate whether ICU patients who developed persistent critical illness displayed 
an immune profile similar to an aged immune phenotype and any associations with patient outcomes. 
Twenty two critically ill ICU patients (27–76 years, 15 males), at day 5 of mechanical ventilation, and 
22 healthy age-matched controls (27–77 years, 13 males) were recruited. Frequency and phenotype 
of innate and adaptive immune cells and telomere length in peripheral blood mononuclear cells 
(PBMCs) were measured. An elevated granulocyte count (p < 0.0001), increased numbers of immature 
granulocytes (p < 0.0001), increased CD16++ve monocytes (p = 0.003) and CD14+ve HLADRdim/low 
monocytes (p = 0.004) and lower NK cell numbers (p = 0.007) were observed in ICU patients compared 
to controls. Critically ill patients also had lower numbers of total T lymphocytes (p = 0.03), naïve CD4 
T cells (p = 0.003) and PTK7+ve recent thymic emigrants (p = 0.002), and increased senescent CD28−ve 
CD57+ve CD4 T cells (p = 0.02), but there was no difference in PBMC telomere length. Regulatory 
immune cell frequency was affected with reduced circulating CD19+veCD24hiCD38hi regulatory B cells 
(p = 0.02). However, only a raised neutrophil:lymphocyte ratio and reduced frequency of CD14+ve 
HLADRdim/low monocytes were associated with poor outcomes. We conclude that persistent critical 
illness results in changes to immune cell phenotype only some of which are similar to that seen in 
physiological ageing of the immune system.
According to the Hospital Episode Statistics Analysis report for 2014, approximately 250,000 patients were admit-
ted to intensive care units (ICU) in the UK1. Patients in these wards are heterogeneous clinically and suffer from 
life threatening conditions including: sepsis/infection; renal failure; cardiac surgery and major trauma.
Critically ill patients often show symptoms typically involving an initial systemic inflammatory response 
syndrome (SIRS), characterised by the release of pro-inflammatory mediators2. SIRS is initially caused by 
non-infective events, such as cardiogenic shock, resuscitation, surgery, or trauma-related tissue damage and 
affects almost half of patients admitted to ICU3. SIRS is accompanied by a compensatory anti-inflammatory 
response syndrome (CARS) initiated to dampen the inflammatory process and aid return to homeostasis4. Either 
an excessive CARs or an insufficient SIRs response will render the host susceptible to infections or unable to clear 
existing infections5. Nosocomial infections in critically ill patients are associated with an increased length of hos-
pital stay, elevated health care costs and increased mortality6.
Persistent critical illness can be defined as occurring when a patient’s reason for being in ICU is more related 
to their ongoing critical illness than their original reason for admission7. This has been shown to occur by day 10 
of ICU, at which time antecedent patient characteristics such as age, sex and chronic health status predict survival 
more accurately than reason for admission and physiological derangement8. These patients have a higher mor-
tality and consume significant resource, so a better understanding of the pathophysiology of persistent critical 
illness is required.
Immunoparesis is seen post critical illness and involves alterations in both innate and adaptive immune 
responses, including neutrophil dysfunction9, altered monocyte phenotype and antigen presentation capac-
ity10, lymphopenia and impaired lymphocyte responses to novel challenge11 and elevated pro-inflammatory 
cytokines12. The clinical consequences of immune suppression in the ICU setting include increased risk of 
1Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK. 2NIHR Surgical Reconstruction 
and Microbiology Research Centre, University Hospital Birmingham, Mindelsohn Way, Birmingham, UK. 3NIHR 
Birmingham Biomedical Research Centre, University Hospital Birmingham, Mindelsohn Way, Birmingham, UK. 
Correspondence and requests for materials should be addressed to J.M.L. (email: J.M.Lord@bham.ac.uk)
Received: 1 September 2017
Accepted: 15 June 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2ScIeNtIfIc REPORTS |  (2018) 8:10186  | DOI:10.1038/s41598-018-28409-7
multiple organ failure, infections and mortality13–15. A balanced systemic host immune response is necessary to 
cope with critical illness and improved understanding of the effect of persistent critical illness on immunity will 
potentially identify novel prognostic biomarkers and routes to therapy.
Although there are some studies that have looked at immune compromise following major trauma, including 
from our own group16,17, there are no comprehensive studies exploring the effect of persistent critical illness in its 
broadest context on innate and adaptive immune cells. In this study we aimed to carry out a detailed assessment 
of the composition of the innate (monocyte, NK cells) and adaptive (T cells and B cells) arms of the immune 
system in a critical care population. We specifically chose a population most at risk of persistent critical illness 
and the consequent high mortality and long term sequelae by recruiting patients who had been mechanically 
ventilated for 5 days.
Lastly, physiological ageing is accompanied by significant remodelling of the immune system termed 
immunesenescence, which includes: thymic atrophy leading to a reduced output of naïve T cells; increased fre-
quency of senescent T cells with shortened telomeres; reduced regulatory cell function; skewing of haemopoiesis 
towards myeloid cell generation; reduced innate cell bactericidal function, and increased systemic inflamma-
tion18. The clinical consequences of immunesenescence include increased risk of infections, autoimmune dis-
ease and chronic inflammatory disease19, which might also be a contributing factor towards the poor outcome 
observed in ICU patients. We thus also attempted to test the hypothesis that persistent critically ill ICU patients 
develop an aged immune phenotype and identify potential immune biomarkers that could predict outcome in 
critically ill patients.
Results
Participant demographics. The baseline characteristics of 22 critically ill patients (range 27–76 years, 15 
males) and 22 age matched healthy controls (range 27–77 years, 13 males) are shown in Table 1. On admission 
to the ICU patients had a mean APACHE II score of 18.13 ± 6.62 and on day 5 they had a mean SOFA score of 
10.73 ± 4.93. Patients had an average length of stay in ICU of 20.94 days. Sepsis was the major primary diagnosis 
(8 patients).
Neutrophil count and neutrophil:lymphocyte ratio. The peripheral granulocyte count was signifi-
cantly higher in critically ill patients compared to healthy controls, p < 0.0001 (Fig. 1a) and there was a significant 
positive correlation between granulocyte numbers and SOFA score, p = 0.01 R2 = 0.25 (Fig. 1b). Additionally, the 
number of immature granulocytes, which have reduced bactericidal function, in critically ill patients was signif-
icantly higher than in healthy controls, p < 0.0001 (Fig. 1c). The neutrophil:lymphocyte ratio was significantly 
higher in critically ill patients compared to controls, p = 0.0002 (Fig. 1d) and was positively associated with ICU 
length of stay, p = 0.04 R2 = 0.19 (Fig. 1e).
Monocyte subset distribution in critically ill patients. The total monocyte count was also significantly 
higher in critically ill patients compared to age matched healthy controls, p = 0.008. The differential expression 
of CD14 and CD16 has been used to define three peripheral subsets of monocytes: classical (CD14+ CD16−) rep-
resent approximately 90% of monocytes in a healthy individual; intermediate (CD14+ CD16+) and non-classical 
monocytes (CD14+ CD16++) make up the remaining fraction20. On comparing the peripheral frequency of 
CD16−ve, CD16+ve and CD16++ve monocytes between controls and critically ill patients no significant difference 
was observed, p = 0.48, p = 0.67 and p = 0.15 respectively. However, the absolute numbers of CD16−ve, CD16+ve 
and CD16++ve monocytes were higher in critically ill patients, p = 0.006, p = 0.001 and p = 0.003 respectively 
(Fig. 2a–c).
CD14+ve HLADRdim/low monocytes have been reported to have an immunosuppressive phenotype21. The gat-
ing used to identify these cells is shown in Fig. 2d. The frequency (Fig. 2e) and absolute numbers (Fig. 2f) of 
ICU patients 
(n = 22)
Healthy controls 
(n = 22)
Age 59.32 ± 13.82 61.23 ± 0.14.88
Male gender, n (%) 15 (68.18%) 13 (59%)
Mortality, n (%) 2 (9.09%) x
SOFA score 10.73 ± 4.93 x
APACHE II score 18.13 ± 6.62 x
ICU Length of stay (days) 20.94 ± 12.71 x
Primary diagnosis
Sepsis 8 (36.3%)
Cardiac surgery 3 (13.6%)
Poly trauma 3 (13.6%)
Kidney failure 3 (13.6%)
Respiratory failure 1 (4.54%)
Liver Cirrhosis 1 (4.54%)
Other 3 (13.6%)
Table 1. Patient demographics.
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CD14+ve HLADRdim/low monocytes was higher in critically ill patients compared to controls, p = 0.03, p = 0.004 
respectively. Interestingly, a positive correlation was observed between the frequency of CD14+ve HLADRdim/low 
monocytes and SOFA score in ICU patients, p = 0.04 R2 = 0.25 (Fig. 2g).
NK cells in critically ill patients. A significant reduction in the frequency of NK cells in the PBMC pool, 
p = 0.001 (Fig. 3a) and the absolute numbers of these cells p = 0.009, (Fig. 3b) was observed in critically ill 
patients. NK cells have been divided into two subsets on the basis of their relative expression of CD56, namely 
CD56dim and CD56bright. The gating strategy used to identify these subtypes is shown in Fig. 3c. 85% of NK cells 
are CD56dim and these cells have high cytotoxic potential, their frequency p = 0.001 (Fig. 3d) and absolute num-
bers p = 0.002 were significantly reduced in critically ill patients. Similarly, a lower frequency p = 0.007 (Fig. 3e) 
and absolute numbers of CD56bright NK cells p = 0.008 was also seen in critically ill patients.
T cell subset distribution in critically ill patients. Functional subsets of T cells include CD4+ve T helper 
cells and CD8+ve cytotoxic cells. The frequency p = 0.003 (Fig. 4a) and absolute number of T cells, p = 0.03 was 
lower in critically ill patients. This was driven by a significant reduction in the frequency p = 0.03 (Fig. 4b) and 
absolute numbers, p = 0.004 of CD4 T cells in critically ill patients. No significant differences were observed for 
CD8 T cells between critically ill patients and healthy controls (Fig. 4c).
We examined the CD4 T cell population further and found that the frequency of naïve CD4 T cells was not 
significantly different in critically ill patients, p = 0.42, but the absolute cell count was lower compared to healthy 
controls, p = 0.003 (Fig. 4d). No significant differences were observed in frequency, p = 0.19 or absolute numbers 
of CD4 memory T cells, p = 0.28 (Fig. 4e). Overall, the CD4 naïve:memory ratio did not differ between healthy 
controls and critically ill patients, p = 0.36. PTK7 has been identified as a novel marker for the identification of 
CD4 recent thymic emigrants (RTEs) indirectly indicating thymic output22. To determine the contribution of 
RTEs and reduced thymic output to the fall in naïve CD4 T cells PTK7+ve cells were enumerated and found to be 
lower in critically ill patients, p = 0.002 (Fig. 4f).
Senescent T cells. T cells have a finite replicative potential, and repeated cell division results in telomere short-
ening and functional senescence. The loss of CD28, gain of CD57 and killer cell lectin–like receptor (KLRG1) are 
cell surface markers used to identify senescent T cells in humans23. The frequency of CD28−ve CD57+ve CD4 T cells, 
Figure 1. Neutrophil count and neutrophil:lymphocyte ratio. (a) Blood neutrophil count in critically ill patients 
(n = 22) and healthy controls (n = 22). (b) Correlation between neutrophil count and SOFA score in critically ill 
patients (n = 20). (c) Neutrophil:lymphocyte ratio in critically ill patients (n = 22) and healthy controls (n = 22). 
(d) Correlation between neutrophil:lymphocyte ratio and ICU length of stay (days) in critically ill patients 
(n = 19). Data are expressed as mean ± SEM.
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p = 0.02 (Fig. 5a) and CD28−ve CD57+ve CD8 T cells, p = 0.01 (Fig. 5b) was significantly higher in critically ill 
patients. However, the absolute numbers of CD28−ve CD57+ve CD4 T cells, p = 0.52 and CD28−ve CD57+ve CD8 
T cells did not differ in critically ill patients, p = 0.59. Similarly, the frequency of KLRG1+ve CD4 T cells and 
KLRG1+ve CD8 T cells was higher in critically ill patients compared to healthy controls, p < 0.001 (Fig. 5c) and 
p = 0.002 (Fig. 5d) respectively. Again, the absolute numbers of KLRG1+ve CD4 T cells, p = 0.41 and KLRG1+ve 
CD8 T cells, p = 0.60 were not different in the critically ill patients.
Telomere length. Relative telomere length (RTL) in PBMCs compared to the 1301 control cell line was 
calculated for critically ill patients and healthy controls but no significant differences were observed, p = 0.26 
(Fig. 5e).
Figure 2. Monocyte subset distribution in critically ill patients (a) Blood CD14+ve CD16−ve; (b) CD14+ve 
CD16+ve; (c) CD14+ve CD16++ve monocyte counts in critically ill patients at recruitment (n = 20) and healthy 
controls (n = 19). (d) Whole blood was stained with anti-CD14 and HLADR antibodies and monocytes 
(CD14+) gated to identify HLADRdim monocytes. (e) Blood frequency and (f) numbers of CD14+ve HLADRdim 
monocytes in critically ill patients (n = 20) and healthy controls (n = 19). The mean value is indicated by the bar. 
(g) Correlation between frequency of CD14+ve HLADRdim monocyte and SOFA score in critically ill patients 
(n = 17). Data are expressed as mean ± SEM.
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Regulatory T cells. Tregs have been identified as a subpopulation of T cells expressing CD4, CD25 and the 
transcription factor Foxp3 that plays an essential role in Treg cell differentiation and development24. On examining 
the frequency of Tregs, no differences were observed between healthy controls and critically ill patients, p = 0.57 
[Fig. 5f].
B cell subset distribution in critically ill patients. B cells can be divided into three subsets on the basis 
of CD27 and IgD expression; naïve (CD27−ve IgD+ve), switched memory (CD27+ve IgD−ve) and unswitched mem-
ory (CD27+ve IgD+ve) B cells25. Total B cell frequency, p = 0.84 (Fig. 6a) and absolute numbers did not differ 
between our two groups, p = 0.49. The frequency of naïve B cells, p = 0.73 (Fig. 6b) and total memory B cells 
(switched and unswitched memory B cells), p = 0.79 (Fig. 6c) also showed no significant differences between the 
groups. Transitional B cells (CD19+veCD24hiCD38hi) have been reported to exert immunosuppressive properties 
mainly via IL10 production26. CD24hiCD38hi B cell frequency, p = 0.02 (Fig. 6d) and absolute numbers, p = 0.04 
(Fig. 6e) in peripheral blood were significantly lower in critically ill patients.
Discussion
Immunological dysregulation in critically ill patients is a serious challenge in critical care management because its 
occurrence increases risk of secondary infections in ICU patients, which increases their length of stay and health 
care costs. Patients with persistent critical illness have a high mortality and a high risk of long term morbidity. 
From this perspective developing an understanding of the underlying immune response in persistent critical 
illness in its broadest context is essential to improving the management of these patients and avoiding complica-
tions such as sepsis.
One of the hypotheses we were testing here was that the immune system of the persistent critically ill 
patient may develop an aged phenotype. It is well established that the immune system declines with age, termed 
immunesenescence18 and that this contributes to increased risk of infection. Key features of immunesenescence 
are reduced innate cell function27,28, a reduced naïve:memory T cell ratio and thymic output, shorter lymphocyte 
telomeres, increased numbers of functionally senescent T cells29 and reduced B regulatory lymphocyte frequency 
and function30. In this study of 22 ICU patients we found some characteristics of the aged immune phenotype, 
Figure 3. NK cell subsets in critically ill patients (a) Blood frequency and (b) numbers of NK cells in critically 
ill patients (n = 22) and healthy controls (n = 22). Data are expressed as mean ± SEM. (c) PBMCs were stained 
with anti-CD3 and anti-CD56 antibodies to identify CD56dim and CD56bright NK cells. (d) Frequency of CD56dim 
NK cells and (e) CD56bright NK cells in critically ill patients (n = 22) and healthy controls (n = 22).
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most notably in the lymphocyte compartment, but not all suggesting that overt acceleration of immune ageing in 
persistent critical illness does not occur and may be restricted to specific features of adaptive immunity.
We observed a decline in peripheral T cell numbers, which has also been reported during sepsis and SIRS31. 
Here lymphopenia was associated with increased ICU length of stay and in trauma patients it has been reported 
previously to be associated with mortality and multiple organ dysfunction32. Interestingly we found few changes 
in T cell subsets, with the exception of naïve T cells whose frequency declined in ICU patients. Such cells are 
crucial for responding to new antigens and vaccinations and their numbers decline with age due to atrophy of the 
thymus33, the organ in which T cells develop. To determine if this fall in naïve T cells could be due to the impact of 
critical illness on thymic function, a potentially irreversible effect, we measured levels of recent thymic emigrants 
in our patients and found them to be lower than in healthy controls. Our data are in line with findings in murine 
models of sepsis and traumatic injury which reported increased thymic atrophy and reduced thymic output of 
naïve T cells to the periphery34,35. Lastly, an accumulation of senescent (CD28−veCD57+veKLRG1+ve) T cells also 
occurred during critical illness, which has been previously reported in sepsis patients36. The T cell compartment 
thus showed the clearest hallmarks of an aged phenotype.
Regulatory T cells24 and B cells26 play a key role in immune homeostasis. Higher circulating Treg levels have 
been observed in trauma patients37, but we did not see this in our cohort of critically ill patients. The role of Bregs 
in orchestrating critical illness induced immunoparesis has not been explored and here we report a decline in 
circulating Bregs in critically ill patients. Although we did not examine IL10 production by these Bregs, there has 
been a recent study reporting a decline in IL10 producing B cells in brain injury patients38. As the frequency and 
function of these cells declines with age30, this may represent further evidence of immune ageing in the lympho-
cyte compartment.
Neutrophils are key contributors to the immediate innate immune response and we confirmed the well doc-
umented neutrophilia in our critically ill patients. Interestingly we also found an increase in immature gran-
ulocytes in blood, which has been reported in major trauma patients39 but not previously in the broad setting 
of ICU patients. Immature granulocytes are less efficient than mature neutrophils in their bactericidal func-
tion40. An increase in these cells may result in delayed bacterial clearance and increase the risk of infections 
in ICU patients, though a much larger study would be needed to test this proposal. We also identified a raised 
Figure 4. T cell subset distribution in critically ill patients (a) Frequency of total CD3+ve T cells, (b) CD4 T 
cells, (c) CD8 T cells in critically ill patients (n = 22) and healthy controls (n = 22). Numbers of (d) Naïve CD4 
T cells, (e) memory CD4 T cells, (f) PTK7+ve CD45RA CD4 T cells in critically ill patients (n = 22) and healthy 
controls (n = 22). Data are expressed as mean ± SEM.
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neutrophil:lymphocyte ratio and this was associated with increased length of ICU stay. Others have found this 
ratio to be a prognostic indicator of mortality in critically ill patients41 and patients with sepsis42. In a study of 130 
septic shock patients a low neutrophil:lymphocyte ratio upon admission was associated with early death but late 
Figure 5. Accumulation of senescent T cells in critically ill patients (a) Frequency of CD28−ve CD57+ve CD4 
T cells, (b) CD28−ve CD57+ve CD8 T cells, (c) KLRG1+ve CD4 T cells, (d) KLRG1+ve CD8 T cells in critically 
ill patients (n = 22) and healthy controls (n = 22). (e) Relative telomere length (RTL) in PBMCs for ICU 
patients (n = 22) compared to age-matched healthy controls (n = 22). (f) Frequency of CD25+ve Foxp3+ve CD4 
Regulatory T cells in critically ill patients (n = 22) and healthy controls (n = 22). The mean value is indicated by 
the bar.
www.nature.com/scientificreports/
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death was associated with a raised ratio in the first 5 days after admission42. Interestingly a raised neutrophil:lym-
phocyte ratio is a feature of immunesenescence due to altered haemopoiesis favouring the myeloid lineage43. In 
ICU patients this is most likely due to the transient neutrophilia induced by surgery, sepsis or chronic disease in 
these patients.
In relation to monocytes we found an expansion of the inflammatory CD16+ve monocyte subset, which has 
also been observed in sepsis patients44 and in ageing45. Monocytes are known to activate the adaptive immune 
response via presentation of antigens on cell surface class II MHC molecules (HLADR). We found an elevated 
frequency of an immunosuppressive HLADRdim/−ve monocyte subset in critically ill patients. Reduced monocyte 
HLADR expression has been previously reported in trauma46 and sepsis patients47,48 and has also been proposed 
as a marker of immune deficiency. Interestingly, we have also observed a positive association between SOFA score 
and the frequency of HLADRdim/−ve monocytes which has also been previously reported in sepsis patients49.
Natural Killer (NK) cells are cytotoxic cells that are responsible for killing virus infected cells and are also an 
important source of inflammatory cytokines, such as IFNγ50. We report here a state of NK cell lymphopenia in 
critically ill patients, which has been previously reported in sepsis patients51 and also recently in traumatic injury 
patients16 and might be due to rapid recruitment of NK cells to sites of inflammation. We did not however find an 
association between NK cell numbers and patient outcomes.
This study has a number of limitations. Firstly, only a small number of ICU patients, 22, were enrolled in 
this study and it was a single centre study. However the heterogeneity of ICU admission causes, ranging from 
cardiac arrest to liver cirrhosis suggests the broad generalisability of the data. Secondly, immune parameters were 
only measured at day 5 post ventilation and we were not able to follow ICU patients after hospital discharge to 
determine whether immune suppression recovered long term post ICU discharge. There were also issues with 
obtaining sufficient blood for all of the assays that we had planned and thus there are uneven numbers for some 
of the measures examined. Finally, we did not measure immune cell function, only phenotype and future studies 
should carry out such measures to confirm reduced immunity in these patients.
We conclude that persistent critical illness induces some remodelling of the adaptive immune cell populations, 
with evidence of a phenotype similar to age-related immune decline in lymphocytes, notably reduced thymic 
output, increased frequency of senescent T cells and reduced regulatory B cells. We have identified an increased 
Figure 6. B cell subset distribution in critically ill patients Frequency of (a) CD19+ve B cells, (b) naïve IgD+ve 
CD27−ve CD19+ve B cells, (c) total memory B cells, (d) CD19+veCD24hiCD38hi B cells in critically ill patients 
(n = 22) and healthy controls (n = 22). The mean value is indicated by the bar. The absolute number of (e) 
CD19+veCD24hiCD38hi B cells in peripheral blood of healthy young (n = 22) and old donors (n = 22). Data are 
expressed as mean ± SEM.
www.nature.com/scientificreports/
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neutrophil:lymphocyte ratio and loss of monocyte HLADR expression as biomarkers for increased length of stay 
in critically ill patients.
Methods
Participants and study design. This was a single centre observational study in critically ill patients (n = 22) 
admitted to the ICU wards of the Queen Elizabeth Hospital, Birmingham between January and September 2016 
that were a part of a trial of rehabilitation in the ICU (ISRCTN90103222). Ethical approval was granted by the 
East Midlands Nottingham and the University of Birmingham Research Ethics Committees. Recruitment of ICU 
patients was conducted on day 5 of mechanical ventilation of the patients. All patients lacked capacity at the time 
of recruitment. Written informed assent was gained from the patient’s advocate or if no advocate then an inde-
pendent Registered Medical Practitioner gave their assent. If the patient later regained capacity then written con-
sent was sought for agreement to continue in the study. 22 healthy age-matched controls were also recruited and 
gave written informed consent for their participation in the study. The baseline demographics, cause of admission 
and clinical history of all patients were recorded. Disease severity was quantified upon admission to ICU using 
the Acute Physiology and Chronic Health Evaluation II (APACHE II)52 and then reassessed on day 5 using the 
Sequential Organ Failure Assessment score (SOFA)53. Blood samples were taken on recruitment to the study. All 
experiments were performed in accordance with the study protocol and all relevant guidelines and regulations.
Blood sampling and monocyte phenotyping. Venous blood samples (6 ml) were collected in lithium 
heparin coated vacutainers. Whole blood counts were performed using a Sysmex XN-1000 haematology analyser 
(Sysmex, UK). The blood was immediately centrifuged at 430 × g for 8 min at room temperature to obtain 
plasma that was stored at −80 °C for future analysis. For monocyte phenotyping whole blood was incubated 
with antibodies, namely anti-human CD14-Pac blue (Bio Legend, UK; clone M5E2), anti-human CD16-FITC 
(eBiosciences, UK; clone CB16) and anti-human HLADR-PE (Serotec, UK; clone: MCA1879) in the dark for 
20 min at 4 °C. Post incubation red blood cells were lysed with 2 mL FACS lysing solution (Becton Dickinson, 
UK) and the samples incubated for 30 min in the dark at room temperature. The samples were then centrifuged 
at 300 × g for 10 min and washed in 2 ml phosphate buffer saline (PBS). A Cyan ADP flow cytometer was used for 
data acquisition and analysis. Each event was recorded in a forward‐side scatter plot in which monocytes were 
located according to their forward scatter profile. The gating strategy for monocyte subsets has been reported 
previously54.
Isolation and freezing of peripheral blood mononuclear cells. Peripheral blood mononuclear 
cells (PBMCs) were isolated from peripheral blood by density centrifugation using Ficoll-PaqueTM PLUS (GE 
Healthcare, Sweden). Isolated PBMCs were frozen down by re-suspending cells in freezing medium consisting 
of 10% DMSO (Sigma Aldrich, UK) in heat inactivated fetal calf serum (Biosera, UK) and the frozen cells were 
then stored at −80 °C.
Surface immunostaining of PBMCs. Frozen PBMCs were thawed at 37 °C and washed in 10 ml RPMI 
1640 (Sigma-Aldrich, UK) and the pelleted cells re-suspended in PBS (1 × 106 cells/ml) with any dead cells 
removed by centrifugation prior to immunostaining. Comparison of fresh and thawed cells from the same donor 
confirmed no preferential loss of specific cell types as a result of freeze-thawing (data not shown). Cells were 
stained with combinations of antibodies, with appropriate isotype controls used for setting gates and the percent-
age of positively stained cells was used to give cell frequency. The gating strategy used to identify T cell subsets55 
and regulatory B cells, Bregs30 were as reported previously.
The antibodies used were: anti-human CD3-PEcy7 (eBiosciences, clone: UCHT1); anti-human CD4 Violet 
(eBiosciences, clone: RPA-T4); anti-human CD8 PE (Immunotools, clone: UCHT4); anti-human CCR7 FITC 
(R & D systems, clone: 150503); anti-human CD45RA APC (Biolegend, clone: HI-100); anti-human CD28 APC 
(BD Biosciences, clone: CD28.2); anti-human CD57 FITC (eBiosciences, clone: HCD57); anti-human PTK7 
(Miltenyi Biotech, clone: 188B) and anti-human CD56 PE (Milenyl Biotech, clone: AF12-7H3). For identification 
of B cell subsets PBMCs were stained with combinations of antibodies: anti-human CD19-PE (eBiosciences, 
clone: HIB19); anti-human CD27-APC (eBiosciences, clone: O323); anti-human IgD-FITC (eBiosciences, clone: 
IA6-2) anti-human CD24-FITC (eBiosciences, clone: eBioSN3) and anti-human CD38-PEcy7 (eBiosciences, 
clone: HIT2). Following incubation, cells were washed and resuspended in PBS for flow cytometric analysis using 
a CyanTM ADP flow cytometer (Dako).
For identification of regulatory T cells PBMCs were stained with anti-human CD3-PEcy7 (eBiosciences, UK, 
clone: UCHT1), anti-human CD4 Alexa fluor 450 (eBiosciences, UK, clone: RPA-T4) and anti-human CD25 APC 
(Biolegend, UK, clone: BC96) antibodies for 20 minutes in the dark at 4 °C. Post incubation cells were washed 
with PBS and re-suspended in 500 µl of Foxp3 Fix Perm Working solution (eBiosciences, UK) and incubated for 
30 minutes in the dark at room temperature. Cells were then washed and resuspended in 100 µl of Foxp3 perme-
abilization buffer (eBiosciences, UK) and stained with anti-human Foxp3 PE antibody (eBiosciences, UK) for 
30 min in the dark at room temperature. Finally, the cells were washed and resuspended in PBS for flow cytomet-
ric analysis using a CyanTM ADP (Dako Ltd, UK).
Data analysis was performed using Summit software. Spectral overlap when using more than one colour was 
corrected via compensation.
Telomere length measurement. Telomere length was analysed in PBMCs using the Telomere peptide 
nucleic acid (PNA) kit/FITC (Dako, UK) according to the manufacturer’s instructions. Briefly, DNA from a 
control cell line (1301) and the test cells was denatured for 10 minutes at 82 °C in hybridisation solution with 
or without an FITC conjugated PNA telomere probe and then hybridised overnight at room temperature in 
the dark. Following two washes the sample was suspended in DNA staining solution. Sample fluorescence was 
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measured using an Accuri C6 Flow Cytometer (BD Accuri, Biosciences) and data were analysed using C-Flow 
Plus Software. Relative telomere length was calculated as the ratio of the telomere fluorescence intensity of the 
sample and control cells, with correction for the DNA index of G0/G1 cells using the formula:
=
− ×
− ×
×
mean FL PBMC sample with probe mean FL PBMC sample without probe DNA index of cells
mean FL cells with probe mean FL cells without probe DNA index of PBMCs
RTL ( 1 1 ) 1301
( 1 1301 1 1301 )
100
Statistical analysis. Statistical analysis was performed using GraphPad Prism® (Graph Pad, La Jolla, USA) 
software. Data distribution was checked using the Kolmogorov-Smirnov test. For normally distributed data, a 
Student’s t test analysis was performed to assess differences between two conditions. P values of <0.05 were 
considered significant. A Bonferroni correction was performed to adjust for the multiple comparisons done on 
the three cohorts and the p values remained significant. To assess the relationship between two variable linear 
regression was used.
Data availability. The primary data included in the manuscript will be made fully available upon publication.
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